title: [Transcutaneous applications for vaccination and immunotherapy].
abstract: Although Edward Jenner applied the first vaccines by scratching cow pox material into the skin, the profound immunological properties of the skin have become evident through research and discoveries only in the last 20 years. The immunological cells in the epidermis and the dermis are suitable targets for transcutaneous vaccination and immunotherapy. However, as the skin represents a natural barrier for topically administered large molecules, novel methods to overcome this barrier function have been described. There are chemical, biochemical and physical methods, many of which are pain-free and therefore especially suitable for children. Also for adults non-invasive methods of vaccination and immunotherapy are attractive as self-administration is feasible. Future products are currently undergoing clinical tests which provide promising results.
authors.affiliation: Dermatologische Klinik, Universität Zürich.
authors.forename: Isabel
authors.initials: I
authors.lastname: Krämer
authors.affiliation: Dermatologische Klinik, Universität Zürich.
authors.forename: Franziska
authors.initials: F
authors.lastname: Zabel
authors.affiliation: Dermatologische Klinik, Universität Zürich.
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Kündig
authors.affiliation: Dermatologische Klinik, Universität Zürich.
authors.forename: Pål
authors.initials: P
authors.lastname: Johansen
mesh_terms: D000279:Administration, Cutaneous; D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D014612:Vaccines / Q000008:administration & dosage*
chemical_list: D014612:Vaccines
keywords: Haut; Immuntherapie; Impfung; Kinder; Transkutan; children; enfants; immune thérapie; immunotherapy; peau; skin; transcutaneous; transcutané; vaccination